Form CORRESP - Correspondence:
SEC Accession No. 0001213900-24-009720
Filing Date
2024-02-02
Accepted
2024-02-02 17:01:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 4542
  Complete submission text file 0001213900-24-009720.txt   5567
Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)